Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain
Anna K. Clark*,,
Ping K. Yip,
John Grist,
Clive Gentry*,
Amelia A. Staniland,
Fabien Marchand,
Maliheh Dehvari,
Glen Wotherspoon*,
Janet Winter*,
Jakir Ullah*,,
Stuart Bevan*,, and
Marzia Malcangio*,,¶
*Novartis Institutes for Biomedical Research, 5 Gower Place, London WC1E 6BS, United Kingdom; and Wolfson Centre for Age Related Diseases, King's College London, Guy's Campus, London SE1 1UL, United Kingdom
Edited by David Julius, University of California, San Francisco, CA, and approved April 25, 2007
Received for publication December 6, 2006.
Abstract:
A recent major conceptual advance has been the recognition ofthe importance of immune systemneuronal interactionsin the modulation of brain function, one example of which isspinal pain processing in neuropathic states. Here, we reportthat in peripheral nerve-injured rats, the lysosomal cysteineprotease cathepsin S (CatS) is critical for the maintenanceof neuropathic pain and spinal microglia activation. After injury,CatS was exclusively expressed by activated microglia in theipsilateral dorsal horn, where expression peaked at day 7, remaininghigh on day 14. Intrathecal delivery of an irreversible CatSinhibitor, morpholinurea-leucine-homophenylalanine-vinyl phenylsulfone (LHVS), was antihyperalgesic and antiallodynic in neuropathicrats and attenuated spinal microglia activation. Consistentwith a pronociceptive role of endogenous CatS, spinal intrathecaldelivery of rat recombinant CatS (rrCatS) induced hyperalgesiaand allodynia in naïve rats and activated p38 mitogen-activatedprotein kinase (MAPK) in spinal cord microglia. A bioinformaticsapproach revealed that the transmembrane chemokine fractalkine(FKN) is a potential substrate for CatS cleavage. We show thatrrCatS incubation reduced the levels of cell-associated FKNin cultured sensory neurons and that a neutralizing antibodyagainst FKN prevented both FKN- and CatS-induced allodynia,hyperalgesia, and p38 MAPK activation. Furthermore, rrCatS inducedallodynia in wild-type but not CX3CR1-knockout mice. We suggestthat under conditions of increased nociception, microglial CatSis responsible for the liberation of neuronal FKN, which stimulatesp38 MAPK phosphorylation in microglia, thereby activating neuronsvia the release of pronociceptive mediators.
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
L. Bryan Ray (26 June 2007) Sci. STKE2007 (392), tw225.
[DOI: 10.1126/stke.3922007tw225] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Fractalkine Signaling in Microglia Contributes to Ectopic Orofacial Pain following Trapezius Muscle Inflammation.
M. Kiyomoto, M. Shinoda, A. Okada-Ogawa, N. Noma, K. Shibuta, Y. Tsuboi, B. J. Sessle, Y. Imamura, and K. Iwata (2013)
J. Neurosci.
33, 7667-7680
|Abstract »|Full Text »|PDF »
Active cathepsins B, L, and S in murine and human pancreatitis.
V. Lyo, F. Cattaruzza, T. N. Kim, A. W. Walker, M. Paulick, D. Cox, J. Cloyd, J. Buxbaum, J. Ostroff, M. Bogyo, et al. (2012)
Am J Physiol Gastrointest Liver Physiol
303, G894-G903
|Abstract »|Full Text »|PDF »
Chronic-Pain-Associated Astrocytic Reaction in the Spinal Cord Dorsal Horn of Human Immunodeficiency Virus-Infected Patients.
Y. Shi, B. B. Gelman, J. G. Lisinicchia, and S.-J. Tang (2012)
J. Neurosci.
32, 10833-10840
|Abstract »|Full Text »|PDF »
CXCL5 Mediates UVB Irradiation-Induced Pain.
J. M. Dawes, M. Calvo, J. R. Perkins, K. J. Paterson, H. Kiesewetter, C. Hobbs, T. K. Y. Kaan, C. Orengo, D. L. H. Bennett, and S. B. McMahon (2011)
Science Translational Medicine
3, 90ra60
|Abstract »|Full Text »|PDF »
Neuregulin-ErbB Signaling Promotes Microglial Proliferation and Chemotaxis Contributing to Microgliosis and Pain after Peripheral Nerve Injury.
M. Calvo, N. Zhu, C. Tsantoulas, Z. Ma, J. Grist, J. A. Loeb, and D. L. H. Bennett (2010)
J. Neurosci.
30, 5437-5450
|Abstract »|Full Text »|PDF »
Interactions between Chemokines: REGULATION OF FRACTALKINE/CX3CL1 HOMEOSTASIS BY SDF/CXCL12 IN CORTICAL NEURONS.
A. Cook, R. Hippensteel, S. Shimizu, J. Nicolai, A. Fatatis, and O. Meucci (2010)
J. Biol. Chem.
285, 10563-10571
|Abstract »|Full Text »|PDF »
Proteomic Analysis Uncovers Novel Actions of the Neurosecretory Protein VGF in Nociceptive Processing.
M. S. Riedl, P. D. Braun, K. F. Kitto, S. A. Roiko, L. B. Anderson, C. N. Honda, C. A. Fairbanks, and L. Vulchanova (2009)
J. Neurosci.
29, 13377-13388
|Abstract »|Full Text »|PDF »
The Liberation of Fractalkine in the Dorsal Horn Requires Microglial Cathepsin S.
A. K. Clark, P. K. Yip, and M. Malcangio (2009)
J. Neurosci.
29, 6945-6954
|Abstract »|Full Text »|PDF »
Interleukin-18-Mediated Microglia/Astrocyte Interaction in the Spinal Cord Enhances Neuropathic Pain Processing after Nerve Injury.
K. Miyoshi, K. Obata, T. Kondo, H. Okamura, and K. Noguchi (2008)
J. Neurosci.
28, 12775-12787
|Abstract »|Full Text »|PDF »
Chemokine Action in the Nervous System.
R. J. Miller, W. Rostene, E. Apartis, G. Banisadr, K. Biber, E. D. Milligan, F. A. White, and J. Zhang (2008)
J. Neurosci.
28, 11792-11795
|Full Text »|PDF »
Crucial Role of CB2 Cannabinoid Receptor in the Regulation of Central Immune Responses during Neuropathic Pain.
I. Racz, X. Nadal, J. Alferink, J. E. Banos, J. Rehnelt, M. Martin, B. Pintado, A. Gutierrez-Adan, E. Sanguino, J. Manzanares, et al. (2008)
J. Neurosci.
28, 12125-12135
|Abstract »|Full Text »|PDF »
Interferon-{gamma} Is a Critical Modulator of CB2 Cannabinoid Receptor Signaling during Neuropathic Pain.
I. Racz, X. Nadal, J. Alferink, J. E. Banos, J. Rehnelt, M. Martin, B. Pintado, A. Gutierrez-Adan, E. Sanguino, N. Bellora, et al. (2008)
J. Neurosci.
28, 12136-12145
|Abstract »|Full Text »|PDF »
Chemokines and the pathophysiology of neuropathic pain.